¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

¼¼ºê¶õ½ºº´¿ø ´ëÇÑÇ÷¾×ÇÐȸ AML/MDS ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2018-09-15

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
¼¼ºê¶õ½ºº´¿ø ´ëÇÑÇ÷¾×ÇÐȸ AML/MDS ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2018-09-15
±³À°ÀÏÀÚ : 2018-09-15
±³À°Àå¼Ò : ¼¼ºê¶õ½ºº´¿ø Á¾ÇÕ°ü 337È£ °­ÀǽǠ 
±³À°ÁÖÁ¦ : AML/MDS ¿¬±¸È¸ ½ÉÆ÷Áö¾ö      
ÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : AML/MDS¿¬±¸È¸  
´ã´çÀÚ : Á¤¼¼¿µ
¿¬¶ôó : 02-533-1408  
À̸ÞÀÏ : seiyoung@yuhs.ac      
±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú      
Âü¼®¿¹»óÀοø : 60¸í
Èñ¸ÁÆòÁ¡ : 4Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 4 ½Ã°£ 25ºÐ  
¼¼ºÎ¼ö°­·á : 0¿ø      
ºñ°í       
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09¿ù 15ÀÏ Á¾ÇÕ°ü 337È£ 09:50~10:20 Long term use of hypomethylating agents for MDS  Á¤ÁØ¿ø(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 09¿ù 15ÀÏ Á¾ÇÕ°ü 337È£ 10:20~10:50 JALSG AML/MDS/CMML Clinical observational study -Preliminary report of the MDS part-  Kensuke Usuki(NTT Medical Center Tokyo) 
±³À°½Ã°£ 09¿ù 15ÀÏ Á¾ÇÕ°ü 337È£ 10:50~11:20 Genetic mutations and decision-making of treatment options for MDS  ±èÀ¯Áø(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 09¿ù 15ÀÏ Á¾ÇÕ°ü 337È£ 11:20~11:50 Preliminary report of AZA trial for high risk MDS, MDS212 on behalf of JALSG  Yasushi Miyazaki(Nagasaki University) 
±³À°½Ã°£ 09¿ù 15ÀÏ Á¾ÇÕ°ü 337È£ 11:50~12:05 Study Proposal (I)- Prospective study of the indUction Regimen for acute non-Promyelocytic myeloid Leukemia in Elderly Hypomethylating agents for favorable risk (PURPLE-H)   ±èÇõ(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 09¿ù 15ÀÏ Á¾ÇÕ°ü 337È£ 12:05~12:20 Study Proposal (II) - Beyond hypomethylating agent (HMA) failure in AML patients  ¹Ú½Çºñ¾Æ(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 09¿ù 15ÀÏ Á¾ÇÕ°ü 337È£ 12:20~12:35 Study Proposal (III) - Comparative study on MDS between Korea and Japan  Yasushi Miyazaki(Nagasaki University) 
±³À°½Ã°£ 09¿ù 15ÀÏ Á¾ÇÕ°ü 337È£ 13:30~13:55 Decision between epigenetic therapy and chemotherapy in patients with AML  ÀÌÇý¿ø(±¹¸³¾Ï¼¾Å¸) 
±³À°½Ã°£ 09¿ù 15ÀÏ Á¾ÇÕ°ü 337È£ 13:55~14:20 Genomics of Myeloid Malignancies  Á¶¿µ¿í(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 09¿ù 15ÀÏ Á¾ÇÕ°ü 337È£ 14:30~14:55 Target Therapy  ½Åµ¿¿±(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 09¿ù 15ÀÏ Á¾ÇÕ°ü 337È£ 14:55~15:20 CAR-T Therapy, Immune Checkpoint and Vaccine Approaches in AML  ÀåÁØÈ£(¼º±Õ°üÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ¼¼ºê¶õ½ºº´¿ø ´ëÇÑÇ÷¾×ÇÐȸ AML/MDS ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2018-09-15""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑôÃ߽Űæ¿Ü°úÇÐȸ Á¦32Â÷ Á¤±âÇмú´ëȸ : 2018-09-15
´ÙÀ½±Û °í·Á´ëÇб³ ±¸·Îº´¿ø Çѱ¹ÀÇ·áÀ±¸®ÇÐȸ ÀÇ»çÁ÷À» À§ÇÑ ÀÇ·áÀ±¸® ½ÉÆ÷Áö¾ö : 2018-09-14
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
347 ºÎ»ê ´ëÇѺñ´¢±â°úÇÐȸ ¼Ò¾Æºñ´¢ÀÇÇÐ ¹× ³²¼ºÀÇÇÐ : 2018-09-06 0 848 2018-08-08
346 ±¤ÁÖ ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ Á¦281Â÷ Àü³²Áöȸ Áý´ãȸ : 2018-09-06 0 387 2018-08-08
345 ÀüºÏ ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ ÀÎÁöÁßÀçÄ¡·áÀÇ ½ÇÁ¦¿Í Àü¸Á : 2018-09-04 0 556 2018-08-08
344 ºÎ»ê ºÎ¿ï°æ³»ºÐºñ´ë»çÇÐȸ 9¿ù Á¤±âÁý´ãȸ : 2018-09-04 0 516 2018-08-08
343 ¼­¿ï Á¦42ȸ ÇѸ²´ëÇб³°­³²¼º½Éº´¿ø ¾È°ú Áý´ãȸ : 2018-09-03 0 883 2018-08-08
342 ¼­¿ï ¼øõÇâ´ëÇм­¿ïº´¿ø Á¦42ȸ º¹ºÎÃÊÀ½ÆÄ ¹× ³»½Ã°æÃÊÀ½ÆÄ Áø´Ü ¿öÅ©¼ó : 2018-09-02 0 951 2018-08-08
341 ºÎ»ê Á¦21ȸ ´ëÇѳ»°úÇÐȸ ºÎ»ê°æ³²Áöȸ ¿¬¼ö°­Á : 2018-09-02 0 870 2018-08-08
340 ¼­¿ï 2018 ¼Ò¾Æ³»ºÐºñÇÐȸ ¿¬¼ö°­Á : 2018-09-02 0 1,198 2018-08-08
339 ´ëÀü ´ëÇѳëÀÎÁ¤½ÅÀÇÇÐȸ Á¦10ȸ Ä¡¸ÅÁø·áÀÇ»ç Àü¹®È­±³À° (part4, 2ÀÏÂ÷) : 2018-09-02 0 615 2018-08-08
338 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø Á¦23ȸ ´ç´¢º´ÀÇ ¿À´Ã°ú ³»ÀÏ : 2018-09-02 0 1,421 2018-08-08
337 ¼­¿ï ´ëÇÑû°¢ÇÐȸ 2018 Á¦19Â÷ º¸Ã»±â¿öÅ©¼¥ : 2018-09-02 0 731 2018-08-08
336 ºÎ»ê 2018³â ´ëÇѹ̼¼¼ö¼úÇÐȸ Ãß°è Microsurgery Workshop : 2018-09-02 0 1,063 2018-08-08
335 ´ëÀü ´ëÇÑÀÓ»ó½Å°æ»ý¸®ÇÐȸ Á¦4ȸ ã¾Æ°¡´Â ¿öÅ©¼ó : 2018-09-02 0 1,031 2018-08-08
334 ´ë±¸ ´ë±¸±¤¿ª½ÃÀÇ»çȸ 2018 Á¾ÇÕÇмú´ëȸ : 2018-09-02 0 756 2018-08-08
333 ¼­¿ï 2018³â ´ëÇÑ¿Ü°úÀÇ»çȸ Ã߰迬¼ö°­Á : 2018-09-02 1 3,030 2018-08-08
1391 | 1392 | 1393 | 1394 | 1395 | 1396 | 1397 | 1398 | 1399 | 1400
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷